Associate director
US Food & Drug Administration
Dr. Yow-Ming Wang is currently the Director of Therapeutic Biologics Program in the Office of Clinical Pharmacology at the US Food & Drug Administration (FDA). From 2011 to September 2017, Dr. Wang served as the team leader of Biologics Team in Division of Clinical Pharmacology III; her team was responsible for reviewing submissions of biological products in three clinical divisions. Prior to joining the FDA, she worked in the pharmaceutical industry with experience in small molecules and large molecules. From 2004 to 2011, she worked at Amgen Inc where she supported multiple biologic products in clinical development, in the registration phase and in the post-marketing phase. Prior to that, Dr. Wang supported small molecule drug discovery and development for 11 years at Vertex Pharmaceuticals Inc and at Parke-Davis Pharmaceutical Research. She received her PhD from The Ohio State Univ Coll of Pharmacy with a research focus on pharmacokinetics and biopharmaceutics.